Large-cap Health Care company Elanco Animal Health has logged a 0.8% change today on a trading volume of 203,613. The average volume for the stock is 5,463,385.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. Based in Greenfield, United States the company has 9,000 full time employees and a market cap of $11,258,926,080.
The company is now trading -8.23% away from its average analyst target price of $24.69 per share. The 13 analysts following the stock have set target prices ranging from $18.0 to $30.0, and on average give Elanco Animal Health a rating of buy.
Over the last 52 weeks, ELAN stock has risen 91.7%, which amounts to a 75.9% difference compared to the S&P 500. The stock's 52 week high is $23.7 whereas its 52 week low is $8.02 per share. Based on Elanco Animal Health's average net margin growth of 24.9% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 4,439,000 | 338,000 | 8 | 128.57 |
| 2023 | 4,417,000 | -1,231,000 | -28 | -1300.0 |
| 2022 | 4,411,000 | -78,000 | -2 | 80.0 |
| 2021 | 4,764,000 | -483,000 | -10 | 44.44 |
| 2020 | 3,271,000 | -574,000 | -18 | -1000.0 |
| 2019 | 3,071,000 | 68,000 | 2 |
